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Abstract
The CERN-MEDICIS facility aims to produce emerging medical radionuclides for the ther-
anostics approach in nuclear medicine with mass separation of ion beams. To enhance the
radioisotope yield and purity of collected samples, the resonance ionization laser ion source
MELISSA was constructed, and provided the first laser ions at the facility in 2019. Several
operational tests were accomplished to investigate its performance in preparation for the
upcoming production of terbium radioisotopes, which are of particular interest for medical
applications.
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1 Introduction
The MEDICIS project (MEDical Isotopes Collected from ISOLDE) is devoted to the pro-
duction of a broad range of non-conventional radionuclides, which have a great potential
for nuclear medicine [1]. The dedicated CERN-MEDICIS radioactive ion beam facility was
constructed adjacent to CERN-ISOLDE, and exploits similar operation principles for the
extraction and purification of radioisotopes samples, based on electromagnetic mass sepa-
ration [2]. The MEDICIS facility can either work in a parasitic mode of ISOLDE, by using
the remaining part of the proton beam, which did not interact with ISOLDE target [3], or
process irradiated materials from other facilities, like ILL (Grenoble, France), GIP Arronax
(Nantes, France), etc.
Terbium (Tb) is the only element in Mendeleev’s periodic table, which possesses four
complementary medically relevant radioisotopes that appear to be well suited for the ther-
anostics approach [4]. Specifically, 149Tb is a promising radionuclide for α-therapy [5, 6];
152Tb and 155Tb can be used for PET and SPECT imaging, respectively [7, 8]; and 161Tb is
appropriate for β−-therapy [9]. With the exception of 161Tb (which can be produced via the
160Gd(n,γ )161Gd → 161Tb reaction at a nuclear reactor), the aforementioned isotopes can
be generated through spallation process Ta(p,x)Tb or irradiating a gadolinium (Gd) target at
an accelerator [10].
The production of Tb radioisotopes is accompanied by isobaric as well as isotopic con-
tamination, which cannot be removed by the standard radiochemical techniques. Mass
separation is mandatory to provide a pure product along with the required specific activity of
a radionuclide. However, the MEDICIS electromagnetic mass separator is unable to separate
isobars. For instance, it was demonstrated that 139Ce16O was present during the extraction
of 155Tb, produced at ISOLDE by irradiation of a tantalum target with high energy proton
beam. 139Ce16O is a thermally ionized isobaric contaminant and is not separated from 155Tb
in the electromagnet. The same concern exists for other stable (e.g. 139La16O, 155Gd) or
radioactive (155Eu) impurities [11]. Similar conditions were observed for the shorter-lived
isotope 149Tb, also produced at ISOLDE, where isobaric contaminants 149Eu and 133Ce16O
are limiting the sample purity [12]. Furthermore, the separation technique was developed
to extract minute quantities of radioisotopes. The question remains if the technique, in its
current form, can cope with high throughput, being necessary to provide a large-scale pro-
duction of Tb radioisotopes. The use of thermal ionization only achieves a few percent for
the overall separation efficiency [13], hampering the collection of a medically sufficient
amount of radionuclides.
The use of a resonance ionization laser ion source [14] in combination with electromag-
netic mass separation allows to improve the ion beam purity by specifically enhancing the
ionization efficiency of the desired element. This technique utilises multiple lasers precisely
tuned to transitions between atomic energy levels to stepwise excite and ionize isotopes of
the element of interest [15]. Subsequently, the element-selective ionization process reduces
the impact of any isobaric contaminants, assisting to achieve a high specific activity [16].
Efficiencies in the tens of percent range are commonly achieved with the laser ion source so
that, when applicable, this is an effective means of maximising the overall radioisotope yield
[17]. This unrivalled combination of element selectivity and high ionization efficiency made
laser ion sources commonplace at radioactive ion beam facilities worldwide [18]. Construc-
tion works on the MEDICIS Laser Ion Source for Separator Assembly (MELISSA) was
completed in 2019. Here a report on delivery of the first laser ions at the CERN-MEDICIS
facility will be presented.
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Fig. 1 MEDICIS Separator Assembly Layout
2 Experimental setup
The MEDICIS Separator consists of a target-ion source assembly, ion extraction system
and a 55-degree double focusing magnet with a bending radius of 1.5 m providing a mass
resolving power of around 400, all of which are enclosed in the Mass Separator Bunker
[19]. The radioisotope collector is located in the Radiochemical Laboratory. The MELISSA
Laser Lab hosts the laser installation required for the operation of the laser ion source
(Fig. 1). Preliminary irradiated target materials or samples containing radioactive isotopes
of interest are enclosed in a target container, which is connected to a hot cavity ion source
through a transfer line. The container and ion source cavity can be independently heated
to temperatures of 2000-2500◦C. This is necessary for the temperature-dependent release
process of atoms from the target container into the cavity [20]. The atoms are then ion-
ized via the element-selective laser ionization process. The resulting ions are extracted by
up to 60 kV accelerating potential, focused by ion optics, separated by their mass-to-charge
ratio in the dipole electromagnet, and guided towards the collector. Finally, only the desired
radioisotope should be collected.
A quantified stable Tb sample with 2 × 1017 atoms (50 μl of an AAS standard solution
from Alfa Aesar) was placed inside the target container. For the measurement, a target unit
(675M) with rhenium hot cavity ion source was operated, which was used before for tests of
the Tb production yield only with surface ionization. As Tb radioisotopes will be produced
by irradiation of a Gd target material [10], the presence of a macroscopic amount of Gd
from previous tests in the target container will help to simulate the anticipated operating
conditions.
A detailed description of the MELISSA setup is presented in [21]. In brief, it comprises
an all-solid-state laser system, based on Ti:Sapphire lasers developed at Mainz University
[22]. To demonstrate the operation of MELISSA, a simplified two-step single-colour laser
resonance ionization scheme for Tb was used, which is shown in Fig. 2. It was developed
at Mainz University during laser spectroscopic investigations of the Tb atomic structure
(details on the Tb laser spectroscopy will be published separately [23]). The excitation
scheme begins from the thermally populated state 462.08 cm−1, and, through the excited
state at 25 076.26 cm−1 [24, 25], it leads to the auto-ionizing state of 49 690.15 cm−1.
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Fig. 2 A two-step single-colour laser resonance ionization scheme for terbium (right) and its saturation curve
(left). The laser power was measured directly at the output of the Ti:Sapphire laser
A single-colour ionization scheme is remarkably convenient for commissioning, because
the relative timing between laser pulses and their spatial overlap do not need to be con-
sidered, compared to most ionization schemes that require 2-3 different laser beams. For
the measurement, one standard “Z” cavity Ti:Sapphire laser was used, pumped by 8 W of
output power from an InnoLas Nanio 532-18-Y laser. The required 406-nm laser light was
produced via intra-cavity frequency doubling [26], providing up to 1.1 W of output power.
The transport efficiency of the optical path was measured to be approximately 70% from
the laser lab to the entrance window of the mass separator. The measurement of this value
up to the hot cavity is difficult; but as the separator window is of high quality and uncoated,
and there are no further optical elements between the window and the ion source, and the
laser beam spot size in the separator is less than 3 mm, the losses between the window and
the hot cavity can be neglected.
3 Results and discussion
The first laser ions provided by MELISSA were measured on 24th April 2019. Several
operational tests were performed to characterize the laser ion source, and to localize possible
weaknesses. The rhenium ion source was operated at a constant temperature of 2270◦C
during all measurements.
The performance of the resonance ionization scheme at different target temperatures is
shown in Fig. 3. One can clearly see that laser ionization has increased the ion signal of Tb
by a factor of 15 (target container temperature of 1480◦C), as given by the ratio between
”laser ON” and ”laser OFF” mode (laser+surface vs. only surface ionization). At higher
operating temperatures, the enhancement factor decreases due to the increased overall sur-
face ionization rate. An enhancement factor of 7 was seen even at the highest operating
temperature tested (2025◦C).
Naturally, the total ion current (measured without lasers) is also significantly increased
at the maximal temperature. The presence of an excess of ions in the hot cavity can cause a
space-charge effect, which will influence the overall performance of the separator assembly.
It is observed that, when a total ion current exceeds 100 nA, the ion source efficiency begins
to decrease. Therefore, the effect of sample outgassing and a consequential excess of ions in
the hot cavity must be taken into account, when the mass separator operation is optimized
Hyperfine Interactions          (2020) 241:55 Page 5 of 9   55 
1400 1500 1600 1700 1800 1900 2000 2100
0.01
0.1
1
10
100
1000
0
3
6
9
12
15
Tb
La
se
rO
N/
OF
Fr
at
io
Io
n
sig
na
l(
nA
)
Target container temperature (°C)
Tb-159 ON
Tb-159 OFF
Gd-158 ON
Gd-158 OFF
Total Current
Fig. 3 Ion signal behaviour for different target container temperatures measured at different masses (158
and 159 u) with lasers switched ON and OFF. The rhenium ion source was operated at 2270◦C. The total ion
current does not include a contribution from laser ions as the Faraday cup, used during this measurement,
blocks the laser beam path to the source
to achieve the maximum extraction efficiency for the isotope of interest. That should be
considered in future ion source development program.
From the behaviour of the Gd signal (measured at mass 158 u, which represents the most
abundant (25%) natural 158Gd isotope), it can be stated that the laser scheme is sufficiently
element-selective. The laser influence increased the Gd ion signal by less than a factor of
1.3, possibly caused by a nearby resonance in the Gd spectrum. As the real Tb sample will
be produced from a Gd target, it is important to ensure that there will be no detrimental
interference during a Tb collection, namely for 152Tb and 155Tb. As this test was conducted
with a previously used target unit, the relative amounts of Gd and Tb atoms in the target
container were not possible to quantify. In the real target, the surplus of atomic Gd com-
ponents is expected to be several orders of magnitude higher than that of Tb. Moreover,
in production conditions for Tb radioisotope collection, a two-step two-colour ionization
scheme, developed at Mainz University, will be used, which demonstrated better ionization
performance and selectivity than the one used in this work [23]. On the other hand, the
presence of a bulk amount of Gd is still an issue, because in this case the surface-ionized
Gd signal can be comparable, if not superior, to the Tb laser ion signal. The preliminary
solution is a pre-purification of the irradiated target material to reduce the Gd:Tb ratio to a
tolerable level.
The mass spectra in the region of interest, shown in Fig. 4, look promising: the mass
peaks are well-resolved and do not interfere with each other. The 159TbO+ molecular ion
does not appear in a significant amount, confirming the expected chemical behaviour of the
Tb sample. The ion source behaviour, when coupled to the real Gd target used for radioiso-
tope extraction, may differ from that of these tests due to differences in sample outgassing,
neutral atom density and composition, and overall ion throughput, and should be considered
additionally.
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Fig. 4 Mass spectra in the region of terbium and gadolinium isotopes and their oxide sidebands, obtained
with and without lasers
A further test was performed assessing the impact of the laser repetition rate on the Tb
ion signal. The simplified two-step single-colour laser resonance ionization scheme is ideal
for this measurement. Typically, atoms effuse through the hot cavity within 100 μs [27, 28],
which corresponds to at least one interaction with laser pulses at 10 kHz repetition rate.
By raising the laser repetition rate beyond this value, the number of interactions can be
increased, potentially leading to a higher ion signal regardless of atom residence time in
the cavity, as the laser ionisation efficiency is likely less than 100% even if all transitions
are saturated. The pump laser pulse energy was kept constant at 0.8 mJ, what will make
this study valid and independent from a saturation degree of the used scheme (which was
not saturated, Fig. 2). Conclusive measurements were performed up to 16 kHz, as further
increase in the repetition rate induced damage to the Ti:Sapphire crystal.
Results can be found in Table 1. It can be stated that the expected growth of the ion signal
is observed. It was being primarily dependent on the growth of Ti:Sapphire average output
power, not directly proportional to the pump laser power. At the same time, the pulse energy
of the Ti:Sapphire laser was decreased almost by 20%. It means that, even though the atoms
saw more pulses, each pulse had a lower probability of causing ionization. The reduction of
the ion signal, normalized to the Ti:Sapphire laser power, at higher repetition rates confirms
this conclusion.
Nevertheless, the increase of the ion signal was observed. And it can be expected that
the bigger growth will be achieved, if the Ti:Sapphire laser is adapted to operate at a higher
repetition rate without losses of the output pulse energy. On the other hand, it has to be
compromised with an associated risk of an optics damage due to the increased total intra-
cavity power. The increase of the ion signal could be even higher, if the mean residence
time of atoms in the hot cavity is less than the time between laser pulses (100 μs at 10 kHz).
For instance, if the atom residence time is 50 μs, a 2-fold ionization improvement can be
expected for a system with 20 kHz repetition rate and the same pulse energy.
Still more tests and development with representative isotope production samples and
targets are required to optimize operation and sample handling procedures to achieve the
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Table 1 The signal behaviour test for different repetition rates of the pump laser
Repeti- Pump Ti:Sa laser Ti:Sa laser Laser ion Laser ions /
tion rate laser power power pulse energy signal Ti:Sa power
(kHz) (W) (W) (μJ) (nA) (nA/W)
10 8.01 1.08 108 1.77 1.64
12 9.59 1.20 100 1.98 1.65
14 11.21 1.24 88.6 2.03 1.64
16 12.80 1.43 89.4 2.28 1.59
18 14.35 − − − −
The background ion signal was constant at 0.24 nA during the whole measurement. The laser ion signal is
calculated by subtracting the background from the measured ion signal
required throughput and purity of collected nuclides. It concerns not only accelerator-
generated radioisotopes, like Tb/Gd cross-contamination considered in this work, but also
nuclides generated at nuclear reactors, for instance 169Er with an isotopic 168Er interfer-
ence from the target material [13]. In this case, both isotopes will be efficiently ionized by
an element-selective ionization. These situations can cause a significant reduction in the
separation efficiency due to the aforementioned high total current. Resolving such prob-
lems could be possible by applying an isotope-selective ionization scheme (e.g. for 169Er)
or by developing an ion source configuration, which should be adapted for a high ion flux
operation, e.g. [29].
4 Summary and outlook
The resonance ionization laser ion source MELISSA is now in operation and has success-
fully delivered the first laser ions at the CERN-MEDICIS facility. Stable 159Tb laser ions
were produced using a simplified 2-step single-colour laser resonance ionization scheme.
The laser enhancement ratio was investigated over a range of typical operating tempera-
tures promising at least a factor of 7 improvement in efficiency over surface ionization only.
The simplified nature of the resonance ionization scheme allowed the effect of the laser
repetition rate on the ionization efficiency to be investigated.
Presently, the CERN proton accelerator complex is shutdown and will restart in 2021.
During the year 2020, MEDICIS will nevertheless perform separation of Tb radioiso-
topes from externally irradiated Gd targets. As both elements, Tb and Gd, have similar
surface ionization efficiencies, it is important to employ an element-selective ionization
process to achieve a pure radioisotopic yield in combination with the high ionization effi-
ciency. Therewith, MELISSA will become a crucial tool for the production of pure medical
radiolathanides and other relevant nuclides.
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